GlaxoSmithKline Manufacturing S.p.A.
GlaxoSmithKline Manufacturing S.p.A., commonly referred to as GSK, is a prominent player in the pharmaceutical and healthcare industry, headquartered in Italy. Established in the early 2000s, GSK has rapidly evolved, focusing on the development and manufacturing of innovative medicines, vaccines, and consumer healthcare products. With major operational regions across Europe and beyond, GSK is renowned for its commitment to research and development, producing unique offerings that address critical health needs. The company’s core products include vaccines and prescription medications that stand out for their efficacy and safety. GSK's market position is bolstered by its significant achievements in advancing public health, making it a trusted name in the industry. Through its dedication to quality and innovation, GSK continues to play a vital role in improving health outcomes globally.
DitchCarbon Score
How does GlaxoSmithKline Manufacturing S.p.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
GlaxoSmithKline Manufacturing S.p.A.'s score of 59 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
GlaxoSmithKline Manufacturing S.p.A.'s reported carbon emissions
GlaxoSmithKline Manufacturing S.p.A., headquartered in Italy, currently does not provide specific carbon emissions data for the most recent year, as no emissions figures are available. Consequently, there are no reported Scope 1, 2, or 3 emissions figures to analyse. In the absence of concrete emissions data, it is essential to highlight the company's commitment to addressing climate change through various initiatives. However, specific reduction targets or climate pledges have not been disclosed, indicating a potential area for improvement in transparency regarding their environmental impact. As the pharmaceutical industry increasingly prioritises sustainability, GlaxoSmithKline Manufacturing S.p.A. may benefit from establishing clear emissions reduction goals and publicly sharing their progress to align with industry standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
GlaxoSmithKline Manufacturing S.p.A. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
